The Effect of Repetitive Simulation on Developing Social Justice Advocacy Attitudes and Skills

Sponsor
Ege University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05966181
Collaborator
(none)
40
1
2
6
6.6

Study Details

Study Description

Brief Summary

It is a randomized controlled experimental and single-blind study with a pretest-posttest control group design, planned to examine the effect of repeated simulation (standard patient simulation) on improving nursing students' social justice advocacy attitudes and skills.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: experimental group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized controlled experimental study with pretest-posttest control group designrandomized controlled experimental study with pretest-posttest control group design
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
The Effect of Repetitive Simulation on Developing Social Justice Advocacy Attitudes and Skills in Student Nurses
Actual Study Start Date :
Mar 30, 2023
Anticipated Primary Completion Date :
Aug 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

They will perform repetitive simulation (standard patient simulation according to scenarios) with the students in the experimental group.

Behavioral: experimental group
Experimental Group-Repetitive Simulation First simulation application; It will be done in groups of four with a total of 5 groups (n=20). In each scenario, one student in the group will participate in the role of nurse and three other students will participate as audience. Four students in each group will take part in a standard patient simulation consisting of four different scenarios. Second simulation application; It will be carried out with the students in the experimental group about 3-4 weeks after the first simulation. Each student will use one new scenario alone in the second simulation.

Other: control group

A single simulation will be applied to the control group (standard patient simulation according to scenarios).

Behavioral: experimental group
Experimental Group-Repetitive Simulation First simulation application; It will be done in groups of four with a total of 5 groups (n=20). In each scenario, one student in the group will participate in the role of nurse and three other students will participate as audience. Four students in each group will take part in a standard patient simulation consisting of four different scenarios. Second simulation application; It will be carried out with the students in the experimental group about 3-4 weeks after the first simulation. Each student will use one new scenario alone in the second simulation.

Outcome Measures

Primary Outcome Measures

  1. Repetitive simulation [four weeks]

    Repetitive simulation is effective in developing nursing students' social justice advocacy attitudes and skills.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Volunteering to participate in the research Being a 4th year undergraduate nursing student Having completed the theoretical education for vocational courses
Exclusion Criteria:
  • Being a foreign national (due to Turkish speaking/understanding problem)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ege University Izmir Turkey 35100

Sponsors and Collaborators

  • Ege University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Esin Ateş, research assistant, Ege University
ClinicalTrials.gov Identifier:
NCT05966181
Other Study ID Numbers:
  • Ege Uni-NF-11
First Posted:
Jul 28, 2023
Last Update Posted:
Jul 28, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Esin Ateş, research assistant, Ege University

Study Results

No Results Posted as of Jul 28, 2023